Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 24, 2026 | CGS Administrators | Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Pigmented Lesion Assay | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing for Solid Tumors | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Melanoma Risk Stratification Molecular Testing | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Envisiaâ¢, Veracyteâ¢, Idiopathic Pulmonary Fibrosis Diagnostic Test | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | Retired |
| Oct 24, 2026 | CGS Administrators | MDS FISH | Retired |
| Oct 24, 2026 | CGS Administrators | Cystatin C Measurement | Retired |
| Oct 24, 2026 | CGS Administrators | Micro-Invasive Glaucoma Surgery (MIGS) | Retired |
| Oct 24, 2026 | CGS Administrators | Frequency of Hemodialysis | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: EndoPredict Breast Cancer Gene Expression Test | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Prometheus IBD sgi Diagnostic® Policy | Retired |
| Oct 24, 2026 | CGS Administrators | Chiropractic Services | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: DecisionDx-UM (Uveal Melanoma) | Retired |
| Oct 24, 2026 | CGS Administrators | Coenzyme Q10 (CoQ10) | Retired |
| Oct 24, 2026 | CGS Administrators | Bladder/Urothelial Tumor Markers | Retired |
| Oct 24, 2026 | CGS Administrators | GlycoMark® Testing for Glycemic Control | Retired |
| Oct 24, 2026 | CGS Administrators | Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities | Retired |
| Oct 24, 2026 | CGS Administrators | ProMark® Risk Score | Retired |
| Oct 24, 2026 | CGS Administrators | Proton Beam Therapy | Retired |
| Oct 24, 2026 | CGS Administrators | <b> MolDX: HLA-DQB1*06:02 Testing for Narcolepsy</b> | Retired |
| Oct 24, 2026 | CGS Administrators | Transcranial Magnetic Stimulation (TMS) | Retired |
| Oct 24, 2026 | CGS Administrators | Bone Mass Measurement | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Breast Cancer Assay: Prosigna® | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Biomarkers in Cardiovascular Risk Assessment | Retired |
| Oct 24, 2026 | CGS Administrators | Urine Drug Testing | Retired |
| Oct 24, 2026 | CGS Administrators | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Retired |
| Oct 24, 2026 | CGS Administrators | Somatosensory Testing | Retired |
| Oct 24, 2026 | CGS Administrators | Nerve Conduction Studies and Electromyography | Retired |
| Oct 24, 2026 | CGS Administrators | Intravenous Immune Globulin | Retired |
| Oct 24, 2026 | CGS Administrators | Nerve Blocks for Peripheral Neuropathy | Retired |
| Oct 24, 2026 | CGS Administrators | Transtelephonic Spirometry | Retired |
| Oct 24, 2026 | CGS Administrators | Stretta Procedure | Retired |
| Oct 24, 2026 | CGS Administrators | Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians | Retired |
| Oct 24, 2026 | CGS Administrators | Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography) | Retired |
| Oct 24, 2026 | CGS Administrators | Visual Fields Testing | Retired |
| Oct 24, 2026 | CGS Administrators | Ocular Photography - External | Retired |
| Oct 24, 2026 | CGS Administrators | Erythropoiesis Stimulating Agents (ESA) | Retired |
| Oct 24, 2026 | CGS Administrators | Outpatient Psychiatry and Psychology Services | Retired |
| Oct 24, 2026 | CGS Administrators | Transthoracic Echocardiography (TTE) | Retired |
| Oct 24, 2026 | CGS Administrators | Transesophageal Echocardiography (TEE) | Retired |
| Oct 24, 2026 | CGS Administrators | Routine Foot Care and Debridement of Nails | Retired |
| Oct 24, 2026 | CGS Administrators | Psychiatric Partial Hospitalization Programs | Retired |
| Oct 24, 2026 | CGS Administrators | Mohs Micrographic Surgery | Retired |
| Oct 24, 2026 | CGS Administrators | Psychiatric Inpatient Hospitalization | Retired |
| Oct 24, 2026 | CGS Administrators | Ophthalmic Biometry for Intraocular Lens Power Calculation | Retired |
| Oct 24, 2026 | CGS Administrators | Ophthalmic Angiography (Fluorescein and Indocyanine Green) | Retired |